Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Formulation (FDF)
Adalimumab Injection
Injection · 0.8ml: 40mg
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB651)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China, Saudi Arabia
Formulation (FDF)
Benvitimod Cream
Cream · 1% (15g: 0.15g)
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB647)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tolvaptan tablet
tablet
- Therapy
- Nephrology & Urology
- Status
- Official FDF licensing catalog (UB646)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Pretomanid Tablets
Tablets · 200mg
- Therapy
- Respiratory
- Status
- Official FDF licensing catalog (UB645)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Bedaquiline Fumarate Tablets
Tablets · 100mg
- Therapy
- Respiratory
- Status
- Official FDF licensing catalog (UB644)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tenofovir alafenamide Fumarate tablets
tablets
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB637)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Therapy Electrode
—
- Therapy
- Others > Medical Devices & Diagnostics
- Status
- Official FDF licensing catalog (UB636)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- To be assessed
Formulation (FDF)
Medical Tape
—
- Therapy
- Others > Medical Devices & Diagnostics
- Status
- Official FDF licensing catalog (UB635)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- To be assessed
Formulation (FDF)
Disposable neutral electrode
—
- Therapy
- Others > Medical Devices & Diagnostics
- Status
- Official FDF licensing catalog (UB634)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- To be assessed
Formulation (FDF)
Medical ultrasound gel
gel
- Therapy
- Others > Medical Devices & Diagnostics
- Status
- Official FDF licensing catalog (UB633)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- To be assessed
Formulation (FDF)
Disposable ECG electrodes
—
- Therapy
- Others > Medical Devices & Diagnostics
- Status
- Official FDF licensing catalog (UB632)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Rupatadine Fumarate Tablets
Tablets
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB630)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Propofol Medium and Long Chain Fat Emulsion Injection
Injection
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB629)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tofacitinib Citrate Tablets
Tablets
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB628)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China, Malaysia
Formulation (FDF)
Tedizolid Phosphate Tablets
Tablets
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB627)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Moxifloxacin Hydrochloride Tablets
Tablets
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB626)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Irbesartan Tablets
Tablets
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB625)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Esomeprazole Sodium for Injection
for Injection
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB624)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China, United States
Formulation (FDF)
Teatvir+Ritonavir
— · GST-HG171 150mg+Ritonavir 100mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB623)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Hydroxychloroquine Sulfate Tablets
Tablets · 0.2g
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB622)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Rivaroxaban Tablets
Tablets · 10mg; 15mg; 20mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB621)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Dapoxetine hydrochloride tablets
tablets · 30mg
- Therapy
- Others > Men's Health
- Status
- Official FDF licensing catalog (UB620)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tadalafil tablets
tablets · 5mg
- Therapy
- Others > Men's Health
- Status
- Official FDF licensing catalog (UB619)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Sildenafil Citrate Tablets
Tablets · 50mg; 100mg
- Therapy
- Others > Men's Health
- Status
- Official FDF licensing catalog (UB618)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ursodeoxycholic Acid Capsules
Capsules · 250mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB617)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Silibin Meglumine Tablets
Tablets · 50mg; 100mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB616)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tenofovir alafenamide Fumarate Tablets
Tablets · 25mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB615)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Adefovir dipivoxil tablets
tablets · 10mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB614)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Lamivudine tablets
tablets · 100mg; 150mg; 300mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB613)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Entecavir Tablets
Tablets · 0.5mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB612)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Entecavir capsules
capsules · 0.5mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB611)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tenofovir dipifurate fumarate capsules
capsules · 300mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB610)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Travoprost Ophthalmic Solution
Ophthalmic Solution · 2.5ml/0.1mg
- Therapy
- Ophthalmology
- Status
- Official FDF licensing catalog (UB607)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Moxifloxacin Hydrochloride Ophthalmic Solution
Ophthalmic Solution · 5ml/25mg
- Therapy
- Ophthalmology
- Status
- Official FDF licensing catalog (UB606)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Levofloxacin Eye Drops
Eye Drops · 5ml/24.4mg; 0.4ml/1.952mg (Preservative-Free)
- Therapy
- Ophthalmology
- Status
- Official FDF licensing catalog (UB605)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Sodium Hyaluronate Eye Drops
Eye Drops · 5ml/15mg; 10ml/10mg...
- Therapy
- Ophthalmology
- Status
- Official FDF licensing catalog (UB604)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Pranoprofen Eye Drops
Eye Drops · 5ml/5mg
- Therapy
- Ophthalmology
- Status
- Official FDF licensing catalog (UB603)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Bromfenac Sodium Eye Drops
Eye Drops · 5ml/5mg; 0.4ml/0.4mg (Preservative-Free)
- Therapy
- Ophthalmology
- Status
- Official FDF licensing catalog (UB602)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Diquafosol Sodium Eye Drops
Eye Drops · 5ml/150mg
- Therapy
- Ophthalmology
- Status
- Official FDF licensing catalog (UB601)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Oseltamivir Phosphate Capsules
Capsules · 75mg ; 45mg ; 30mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB600)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Semaglutide Injection
Injection · 0.68mg/ml, 1.5ml ; 1.34mg/ml, 1.5ml; 1.34mg/ml, 3ml ; 2.27mg/ml, 3ml; 3.2mg/ml, 3ml
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB599)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Minoxidil Topical Solution
Topical Solution · 60ml/3.0g ; 60ml/1.2g
- Therapy
- Others > Dermatology
- Status
- Official FDF licensing catalog (UB598)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tacrolimus Ointment
Ointment · 10g/10mg ; 10g/3mg
- Therapy
- Others > Dermatology
- Status
- Official FDF licensing catalog (UB597)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tobramycin Sulfate for Injection
for Injection · 80mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB596)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Levofloxacin Eye Drops
Eye Drops · 0.5%（0.3ml:1464mg）
- Therapy
- Ophthalmology
- Status
- Official FDF licensing catalog (UB595)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Bumetanide Injection
Injection · 1ml:0.5mg; 4ml:2mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB594)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Rebamipide Tablets
Tablets · 0.1g
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB593)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Sodium Hyaluronate Eye Drops
Eye Drops · 0.1% (5ml:5mg)
- Therapy
- Ophthalmology
- Status
- Official FDF licensing catalog (UB592)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China